Skip to content

Apria, Inc. (NYSE:APR) Given Average Recommendation of "Buy" by Analysts – MarketBeat

Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Apria, Inc. (NYSE:APR) has been assigned an average rating of “Buy” from the seven brokerages that are currently covering the stock, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $33.08.
APR has been the subject of a number of research analyst reports. Citigroup initiated coverage on shares of Apria in a report on Monday, January 10th. They set a “buy” rating and a $39.00 price objective for the company. Zacks Investment Research raised shares of Apria from a “hold” rating to a “buy” rating and set a $33.00 price objective for the company in a report on Tuesday, December 21st. Piper Sandler downgraded shares of Apria from an “overweight” rating to a “neutral” rating in a report on Monday, January 10th. Finally, UBS Group cut shares of Apria from a “buy” rating to a “neutral” rating and set a $37.50 target price on the stock. in a research report on Tuesday.
In other Apria news, SVP Celina M. Scally sold 1,283 shares of the firm’s stock in a transaction dated Thursday, November 11th. The shares were sold at an average price of $30.76, for a total value of $39,465.08. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Robert P. Walker sold 5,421 shares of Apria stock in a transaction that occurred on Wednesday, December 1st. The shares were sold at an average price of $28.48, for a total value of $154,390.08. The disclosure for this sale can be found here. Insiders sold 392,871 shares of company stock worth $11,788,228 in the last 90 days. (adsbygoogle = window.adsbygoogle || []).push({});
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Advisory Services Network LLC purchased a new position in shares of Apria in the 2nd quarter valued at approximately $28,000. First Mercantile Trust Co. bought a new position in Apria during the 3rd quarter valued at approximately $34,000. First Quadrant L P CA bought a new position in Apria during the 3rd quarter valued at approximately $43,000. Citigroup Inc. increased its position in Apria by 219.3% during the 3rd quarter. Citigroup Inc. now owns 1,973 shares of the company’s stock valued at $73,000 after buying an additional 1,355 shares in the last quarter. Finally, Royal Bank of Canada increased its position in Apria by 141.2% during the 3rd quarter. Royal Bank of Canada now owns 2,103 shares of the company’s stock valued at $78,000 after buying an additional 1,231 shares in the last quarter.
NYSE:APR traded down $0.06 during trading hours on Friday, hitting $37.30. The stock had a trading volume of 1,069,358 shares, compared to its average volume of 805,894. The company has a 50 day simple moving average of $31.49 and a two-hundred day simple moving average of $32.60. The company has a quick ratio of 1.15, a current ratio of 1.18 and a debt-to-equity ratio of 15.18. Apria has a one year low of $20.07 and a one year high of $40.00.
Apria (NYSE:APR) last posted its quarterly earnings data on Thursday, November 4th. The company reported $0.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.48 by $0.04. Apria had a net margin of 6.46% and a negative return on equity of 1,439.24%. The company had revenue of $287.20 million during the quarter, compared to the consensus estimate of $286.00 million. Analysts anticipate that Apria will post 1.81 EPS for the current fiscal year.
About Apria
Apria, Inc provides integrated home healthcare equipment and related services in the United States. The company offers home respiratory therapies, including the supply of stationary and portable home oxygen equipment, and non-invasive ventilators; obstructive sleep apnea therapy devices comprising continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services; and negative pressure wound therapy products.
Recommended Story: No Load Funds
Analyst Recommendations for Apria (NYSE:APR)
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Before you consider Apria, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Apria wasn’t on the list.
While Apria currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The 5 Stocks Here
 
Complete the form below to receive the latest headlines and analysts’ recommendations for your stocks with our free daily email newsletter:
Each market day you’ll get a one-minute market summary to help you invest wisely.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.
As Featured By:
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.
Twitter Facebook StockTwits
MarketBeat is accredited by the Better Business Bureau
© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.

source

Share:

Pulse Handshak

Pulse Handshak

Collaborative online survey tool for the market research industry. Remote assisted surveying just like face-to-face interviews. Here interviewers can talk to the respondent over the web-console without the need for any other communication channel and share the same Q're with responses and click actions.

Pulse FE

Pulse FE

Pulse Field Expert or Pulse FE is the main platform for both offline and online survey at softofficepro.com. It is robust and used by hundreds of clients over tens of years with millions of responses. Do it once Q're and deploy on both offline devices (android) and online forms makes it a great cost effective platform for any kind of responses

Pulse Ultimate

Pulse Ultimate

Pulse Ultimate is targeted for tracking studies and retail audits. An offline survey system offering extreme field control including processes like data quality check, back-check, rework, comparison with previous wave data etc. helps to get the best results on a day-to-day basis

More Posts